C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2009
11/12/2009	WO2009071691A3 Oxindole derivatives and the use thereof as a medication
11/12/2009	US20090281314 Method for producing bicyclic guanidines by use of a cyclic urea and a dehydrating agent
11/12/2009	US20090281310 Cinnamide compound
11/12/2009	US20090281125 Heterocyclic Compounds Useful in Treating Diseases and Conditions
11/12/2009	US20090281122 Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase, and Compositions and Treatments Using the Same
11/12/2009	US20090281121 SUBSTITUTED 8-PIPERIDINYL-2-PYRIDINYL-PYRIMIDO[1,2-a] PYRIMIDIN-6-ONE AND 8-PIPERIDINYL-2-PYRIMIDINYL-PYRIMIDO[1,2-a] PYRIMIDIN-6-ONE DERIVATIVES
11/12/2009	US20090281120 Bicyclic heterocyclic compound
11/12/2009	US20090281118 Selective Ligands for the Neuronal Nicotinic Receptors and Uses Thereof
11/12/2009	US20090281107 Substituted 2,5-dihydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and therapeutic use of the same
11/12/2009	US20090281092 Polo-like kinase inhibitors
11/12/2009	US20090281080 Spirohydantoin Tricyclic CGRP Receptor Antagonists
11/12/2009	US20090281079 Substituted 4-Amino-Pyrrolotriazine Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated With Angiogenesis
11/12/2009	US20090281072 Diaminopyrimidinecarboxamide Derivative
11/12/2009	US20090280081 JAK/STAT pathway inhibitors and uses thereof
11/12/2009	DE102008022788A1 New 2,6-pyrazine bridged transition metal carbene complex useful as a catalyst for oxidation of hydrocarbons
11/12/2009	DE102008022521A1 1,4-Diaryl-pyrimidopyridazin-2,5-dione und ihre Verwendung 1,4-diaryl-pyrimidopyridazin-2,5-diones and their use
11/12/2009	CA2723683A1 7h-indolo[2,1-a] [2] benzazepine-10-carboxylic acid derivatives for the treatment of hepatitis c
11/12/2009	CA2723600A1 Method for producing bicyclic guanidines by use of a cyclic urea
11/12/2009	CA2723237A1 Substituted amides, method of making, and use as btk inhibitors
11/12/2009	CA2723127A1 Inhibitors of protein kinases
11/12/2009	CA2722981A1 Selective ligands for the neuronal nicotinic receptors and uses thereof
11/12/2009	CA2721303A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists
11/12/2009	CA2719234A1 Spiroazaindoles
11/11/2009	EP2116541A1 Proline derivatives and their use as dipeptidyl peptidase IV inhibitors
11/11/2009	EP2116538A1 Condensed tetrahydroquinoline derivative and use thereof for medical purposes
11/11/2009	EP2114948A2 Inhibitors of poly(adp-ribose)polymerase
11/11/2009	EP2114905A1 Multi-color time resolved fluorophores based on macrocyclic lanthanide complexes
11/11/2009	EP2114454A2 Chemical linkers and cleavable substrates and conjugates thereof
11/11/2009	EP2114158A1 3-substituted-[1,2,3]benzotriazinone compounds for enhancing glutamatergic synaptic responses
11/11/2009	EP1960401B1 Tricyclic amide derivatives useful for treating obesity
11/11/2009	EP1841770B1 Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/11/2009	EP1742937B1 Pyrrolopyrimidine derivatives for treating proliferative diseases
11/11/2009	EP1713823B1 Hcv ns-3 serine protease inhibitors
11/11/2009	EP1606255B1 Cyclic derivatives as modulators of chemokine receptor activity
11/11/2009	EP1537104B1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
11/11/2009	CN101578286A Diketopyrrolopyrrole cocrystals with high transparency
11/11/2009	CN101578262A Radiolabelling via fluorination of aziridines
11/11/2009	CN101578100A Use of neuroprotective compounds for obtaining drugs for treating neurodegenerative diseases
11/11/2009	CN101575340A Preparation method of ketorolac tromethamine
11/11/2009	CN101575339A 8-hydroxypyrimido-[3,2-d]pyrimidine-7-carboxylic acid derivatives having anti-HIV activity, preparation method thereof and use thereof
11/11/2009	CN101575338A Amorphous polymorph for pemetrexed disodium and preparation method thereof
11/11/2009	CN100558728C Calcitonin gene related peptide receptor antagonists
11/11/2009	CN100558727C Methods for producing quinazoline alkaloids
11/11/2009	CN100558697C Cycloalkyl inhibitors of potassium channel function
11/10/2009	US7615638 Synthesis of grossularines-1 and analogs thereof and method of use
11/10/2009	US7615633 Organic electroluminescent device and platinum compound
11/10/2009	US7615632 Nine polymorphic crystal structures based on characteristics of powder X-ray diffraction pattern exhibiting peaks at diffraction angles and infrared spectrum; antitumor and -carcinogenic agents; brain and breast cancer; refractory anaplastic astrocytoma; malignant glioma; glioblastoma multiforme
11/10/2009	US7615630 Compound and method for synthesizing the same, ink, ink cartridge, recording unit, ink-jet recording apparatus, recording method, liquid composition, pattern generating method, article, environmental history-detecting method
11/10/2009	US7615567 Such as 2-exo-[5'-(3'-Amino-2'-fluoropyridinyl)]-7-azabicyclo[2.2.1]-heptane; Tourette's syndrome
11/10/2009	US7615558 6-arylmethylprazolo[3,4-d]pyrimidines
11/10/2009	US7615555 Piperidine derivatives as modulators of chemokine receptor CCR5
11/10/2009	US7615550 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
11/10/2009	CA2457952C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h) one derivatives for neurodegenerative disorders
11/05/2009	WO2009134750A1 Benzoimidazoles as prolyl hydroxylase inhibitors
11/05/2009	WO2009134737A1 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
11/05/2009	WO2009134658A2 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
11/05/2009	WO2009134531A2 Total synthesis of salinosporamide a and analogs thereof
11/05/2009	WO2009133127A1 Fused bicyclic compounds and use thereof as pi3k inhibitors
11/05/2009	WO2009132986A1 Imidazolidinone derivatives as 11b-hsd1 inhibitors
11/05/2009	WO2009132921A1 Spiro-indole derivatives for the treatment of parasitic diseases
11/05/2009	WO2009102377A3 Antibiotic tetrahydro-beta-carboline derivatives
11/05/2009	WO2009100996A3 Process for preparing pyrazole functionalized benzodiazepinones
11/05/2009	WO2009092602A3 Anti-angiogenic compounds
11/05/2009	WO2009087225A3 Pyrrolopyrimidines and pyrrolopyridines
11/05/2009	US20090275749 Production method of optically active piperazine compound
11/05/2009	US20090275727 Peptide turn mimetics
11/05/2009	US20090275664 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/05/2009	US20090275616 Straightforward entry to 7-azabicyclo[2.2.1]heptane-1-carbonitriles and subsequent synthesis of epibatidine analogues
11/05/2009	US20090275609 Carboxamide Compounds and Methods for Using The Same
11/05/2009	US20090275606 Heterocyclic Compounds as MEK Inhibitors
11/05/2009	US20090275593 3 Substituted N-(aryl- or heteroaryl)-pyrazolo[1,5-a]pyrimidines as Kinase Inhibitors
11/05/2009	US20090275591 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitor
11/05/2009	US20090275577 Imidazopyridine and imidazopyrimidine derivatives as antibacterial agents
11/05/2009	US20090275576 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
11/05/2009	US20090275573 Imidazolidinone Derivatives as 11B-HSD1 Inhibitors
11/05/2009	US20090275572 Fab i inhibitors
11/05/2009	US20090275561 Compounds for the Treatment of Hepatitis C
11/05/2009	US20090275560 Organic compounds
11/05/2009	US20090275539 Nuclear Transcription Factors Regulators
11/05/2009	US20090275537 Certain chemical entities, compositions, and methods
11/05/2009	US20090275533 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
11/05/2009	US20090275065 Methods and compounds for detecting beta-lactamase activity
11/05/2009	US20090274632 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof
11/05/2009	CA2722772A1 Benzoimidazoles as prolyl hydroxylase inhibitors
11/05/2009	CA2722487A1 Imidazolidinone derivatives as 11b-hsd1 inhibitors
11/05/2009	CA2722285A1 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
11/05/2009	CA2722220A1 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
11/05/2009	CA2720846A1 Novel inhibitors of hepatitis c virus replication
11/05/2009	CA2719365A1 Spiro-indole derivatives for the treatment of parasitic diseases
11/05/2009	CA2717715A1 Total synthesis of salinosporamide a and analogs thereof
11/04/2009	EP2112993A1 Substituted tetrahydropyrrolopyrazine compounds having affinity with the kcnq2/3 k+ channel and use thereof in medicaments
11/04/2009	EP1624874B1 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/04/2009	EP1617806B1 Selective spirocyclic glucocorticoid receptor modulators
11/04/2009	EP1615613B1 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
11/04/2009	EP1481077B1 Mitotic kinesin inhibitors
11/04/2009	EP1432700B1 Spiro-hydantoin compounds useful as anti-inflammatory agents
11/04/2009	EP1339684B1 Mch antagonists and their use in the treatment of obesity
11/04/2009	CN101573363A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
11/04/2009	CN101573360A Heteroaryl compounds, compositions thereof, and methods of treatment therewith
11/03/2009	US7612202 Process for preparing temozolomide

1 ... 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 ... 573